Qiagen N.V. (QGEN)
| Previous Close | 41.52 |
| Open | 40.87 |
| Bid | 40.76 x 800 |
| Ask | 40.78 x 900 |
| Day's Range | 40.56 - 41.04 |
| 52 Week Range | 34.74 - 47.70 |
| Volume | |
| Avg. Volume | 1,017,159 |
| Market Cap | 9.013B |
| Beta (5Y Monthly) | 0.42 |
| PE Ratio (TTM) | 26.79 |
| EPS (TTM) | 1.52 |
| Earnings Date | Apr 29, 2024 |
| Forward Dividend & Yield | 1.28 (2.94%) |
| Ex-Dividend Date | Jan 30, 2024 |
| 1y Target Est | 50.97 |
GlobeNewswireQIAGEN expands tuberculosis portfolio with new NGS Panel to support real-time surveillance and combat antimicrobial resistance
Launch of QIAseq xHYB Mycobacterium tuberculosis Panel for research use, enabling culture-free whole genome sequencing from complex samples // Panel significantly accelerates TB outbreak tracking and supports detection and management of antimicrobial resistance, critical needs in TB surveillance and control // Building upon success of leading diagnostics test QuantiFERON-TB Gold Plus as QIAGEN extends portfolio for TB management and control amid globally rising incidence ratesVenlo, the Netherla
ZacksUnveiling Qiagen (QGEN) Q1 Outlook: Wall Street Estimates for Key Metrics
Evaluate the expected performance of Qiagen (QGEN) for the quarter ended March 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
GlobeNewswireQIAGEN N.V. to release results for Q1 2024 and hold webcast
Venlo, The Netherlands, April 09, 2024 (GLOBE NEWSWIRE) -- QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) announced plans to release results for the first quarter 2024. Press release date / time: Monday, April 29, shortly after 22:05 Frankfurt time / 21:05 London time / 16:05 New York time. Conference call date / time: Tuesday, April 30, at 15:00 Frankfurt time / 14:00 London time / 09:00 New York time. Three options for joining the conference call Register for call back connection - C
